IXFY operates under strict institutional standards of factual verification, editorial independence, and journalistic ethics. Our global reputation rests on the uncompromised accuracy of our reporting, our analytical depth, and our commitment to serving international decision-makers across biotechnology, enterprise technology, capital markets, and regulatory science.

1. Core Journalistic Mission & Objectivity

The editorial mission of IXFY is to provide rigorous, unbiased, and context-rich coverage of technological advancements, commercial breakthroughs, corporate restructuring, and global policy shifts. We prioritize verifiable facts and structural analysis over sensationalism, speculative rumors, and click-driven coverage.

Our journalists, analysts, and contributors approach every beat with impartial skepticism, evaluating claims made by corporate executives, academic institutions, and regulatory agencies against empirical evidence and audited public filings.

2. Factual Verification & Dual-Source Corroboration

Every article published across the IXFY network is subjected to rigorous fact-checking protocols prior to release:

  • Primary Source Supremacy: Financial valuations, funding rounds, revenue figures, and executive appointments must be corroborated against statutory regulatory filings (such as SEC EDGAR, UK Companies House, European ESMA registers), audited annual reports, or direct written corporate confirmation.
  • Scientific & Medical Substantiation: All reporting concerning clinical trial outcomes, biotechnology mechanisms, patent grants, and pharmaceutical approvals must cite primary peer-reviewed literature (e.g., The Lancet, Nature, Science, NEJM) or official regulatory dossiers from the FDA, European Medicines Agency (EMA), or equivalent public health bodies.
  • Dual-Source Corroboration Mandate: In investigative reports and non-public developments, no critical claim, unpublished leak, or anonymous statement is published without independent confirmation from at least two separate, credible industry or regulatory sources.

3. Editorial Independence & Commercial Separation

IXFY maintains a complete, impenetrable firewall between its editorial newsroom and any commercial, advertising, sponsorship, or corporate consulting activities.

  • Zero Commercial Influence: Advertisers, corporate partners, venture backers, and institutional sponsors have zero influence over editorial story selection, headlines, framing, timing of publication, or journalistic conclusions.
  • No Pay-to-Play or Sponsored News: We do not publish paid editorial content, native advertising disguised as journalism, or pay-for-coverage articles. Any sponsored marketing collateral is explicitly marked and separated from the news feed.
  • Editorial Autonomy: No commercial entity or corporate subject is permitted advance access to review, alter, or veto article drafts prior to publication.

4. Conflict of Interest & Market Trading Restrictions

To preserve our readers' absolute trust and eliminate any appearance of bias, all IXFY editorial personnel, beat reporters, and regular columnists are subject to strict ethical trading codes:

  • Prohibition on Active Trading: Journalists covering specific sectors (such as life sciences, artificial intelligence, or semiconductors) are strictly prohibited from trading individual equities, options, or derivative contracts of companies within their active coverage sphere.
  • Mandatory Disclosure: Staff members must disclose any preexisting equity ownership, family employment ties, or advisory relationships involving companies mentioned in their reporting.
  • Gifts and Hospitality Ban: Editorial staff are forbidden from accepting monetary gifts, equity grants, subsidized personal travel, or personal favors from corporate entities, PR agencies, or subjects of reporting.

5. Sourcing, Confidentiality & Whistleblower Protection

Transparency in sourcing is essential to credible journalism:

  • On-the-Record Attribution: We make every reasonable effort to identify sources by full name, professional title, and institutional affiliation.
  • Use of Anonymous Sources: Anonymous attribution is granted only when a source faces legitimate risks of legal retaliation, career termination, or personal endangerment, and the disclosed information is of substantial public importance. The identity of any anonymous source must be vetted and approved by a Senior Desk Editor.
  • Whistleblower Privilege: IXFY exercises all legal privileges and cryptographic security protocols to safeguard the confidentiality of bona fide whistleblowers and journalistic contacts.

6. Transparent Corrections & Retractions Protocol

When factual errors occur, IXFY is committed to rapid, transparent, and public accountability:

  • Material Corrections: If an article contains a substantive factual, numerical, or contextual error, it is corrected immediately. A prominent "Correction Notice" is appended to the bottom or top of the article, specifying the exact date, time, and nature of the correction.
  • Clarifications: When language is ambiguous or warrants additional context without being factually false, an explanatory clarification note is appended.
  • Formal Retractions: In the rare event that an article is found to have relied upon fraudulent documentation or fundamentally flawed premises, it is formally retracted, with an institutional editorial statement explaining the findings.

7. Artificial Intelligence & Algorithmic Tools Charter

As an intelligence platform chronicling the generative AI revolution, IXFY employs modern computing tools responsibly while maintaining human editorial sovereignty:

  • Human-in-the-Loop Imperative: No article, headline, analytical thesis, or investigative piece on IXFY is published without thorough human editorial drafting, line editing, and factual verification. Automated or unreviewed generative AI publishing is strictly prohibited.
  • Research Synthesis Only: Computational and large language model tools are utilized exclusively for background text summarization, multi-language document translation, transcript formatting, and quantitative data parsing.
  • Confidentiality Protection: Proprietary research, unpublished drafts, and whistleblower materials are never inputted into third-party public AI models where data retention could jeopardize source confidentiality.

8. Reader Inquiries & Standards Ombudsperson

We welcome reader scrutiny and constructive feedback. If you identify a factual error, ambiguous attribution, or ethical concern in our reporting, please contact our Editorial Standards Desk directly at corrections@ixfy.net. Every inquiry is reviewed by senior editorial leadership.